• Duphat 2026 MedEdge MEA
  • Dubai Derma 2026 DWTC
  • GHE Riyadh 2026 MedEdge
MedEdge MEA

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: Ebn Sina Medical Partners with BeiGene to Expand Access to Oncology Treatments in Qatar
Share
Notification
  • Duphat 2026 MedEdge MEA
  • Dubai Derma 2026 DWTC
  • GHE Riyadh 2026 MedEdge
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In

Home - Collaborations - Ebn Sina Medical Partners with BeiGene to Expand Access to Oncology Treatments in Qatar

Collaborations

Ebn Sina Medical Partners with BeiGene to Expand Access to Oncology Treatments in Qatar

ME Desk
ME Desk
Published: April 9, 2025
Share
3 Min Read
Ebn Sina
SHARE
google_preferred_source_badge_light_en@2x

Doha, Qatar- April 2025- Ebn Sina Medical, a subsidiary of Aamal Company Q.P.S.C. and a leading supplier of pharmaceutical, hospital, and healthcare products in Qatar, has signed a strategic partnership with BeiGene, a global oncology company. The signing ceremony was attended by Aamalโ€™s CEO, Mr. Rashid bin Ali Al Mansoori, General Manager of Ebn Sina Medical, Dr. Essam Faragalla, and BeiGeneโ€™s Mohammed Al-Kapany, General Manger, Middle East and North Africa Region.

Under this agreement, Ebn Sina Medical will serve as the local partner and distributor for BeiGeneโ€™s range of oncology medicines, enhancing the availability of innovative oncology treatments in Qatar. This collaboration reflects Ebn Sina Medical’s commitment to delivering high-quality medicinal products to the local market, benefiting healthcare providers and patients alike.

Aamal Company CEO, Mr. Rashid bin Ali Al Mansoori, stated: “This collaboration strengthens Qatarโ€™s medical sector by improving patient access to the latest oncology treatments. Ebn Sina Medicalโ€™s strong market position makes it a trusted partner for renowned global pharmaceutical companies like BeiGene. I look forward to seeing the positive impact this partnership will have on healthcare in Qatar.”

Also Read : Cardinal Health Expands Diabetes Care with Acquisition of Advanced Diabetes Supply Group

Mr. Essam Faragalla, General Manager of Ebn Sina Medical, added: “Partnering with BeiGene marks an important step in expanding access to advanced oncology treatments in Qatar. Our goal is to support healthcare professionals with the tools they need to improve patient care. Through strategic collaborations like this, we continue to strengthen the healthcare system and enhance treatment options for patients facing complex health challenges.”

Mohammed Al-Kapany, General Manager, Middle East and North Africa Region at BeiGene, commented: At BeiGene, we are committed to expanding access to innovative and affordable cancer treatments for more patients around the world. This partnership with Ebn Sina Medical reflects our shared goal of improving outcomes for people living with cancer in Qatar. Together, weโ€™re working to ensure that patients and healthcare providers have access to the high-quality therapies they need โ€” where and when they need them.โ€

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Uprise Health Uprise Health Names Rebika Shaw as New CEO
Next Article breastfeeding Why Breastfeeding Is the Ultimate Biohack For Lifelong Health

Recent Posts

  • How a Poorly Maintained AC System Can Cost You Your Health
  • Strategic Partnership to Strengthen Healthcare Workforce Credentialing Across the UAE
  • Advanced Onco-Surgery Services Expand Access to Comprehensive Cancer Care
  • World Brain Day Highlights the Importance of Early Stroke Recognition and Treatment
  • Abu Dhabi Stem Cells Center Achieves Major Scientific Breakthrough in Huntington’s Disease Research
  • DERMA
  • Global Health Riyadh 2026 MedEdge MEA
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Ebn Sina Medical Partners with BeiGene to Expand Access to Oncology Treatments in Qatar
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Ebn Sina Medical Partners with BeiGene to Expand Access to Oncology Treatments in Qatar
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?